-
Joining by phone ONLY:
+1 204 272 7920 Canada
+1 438 809 7799 Canada
+1 587 328 1099 Canada
+1 647 374 4685 Canada
+1 647 558 0588 Canada
+1 778 907 2071 Canada
+1 780 666 0144 Canada
Meeting ID: 986 8740 4228
Find your local number: https://echo.zoom.us/u/kdeYJ8w8oS
Press *6 to mute your line when not speaking
Password: boreal
Session Resources
the Ottawa M&M Model: A Guide to Enhancing Morbidity & Mortality Rounds (2016)
Yu, J. T., Li, C. P., Huang, T. M., & Tsai, R. Y. (2026). Beyond Conventional Analgesics: Updated Evidence Supporting Botulinum Toxin Type A for-Neuralgia Management. International journal of medical sciences, 23(4), 1456–1469. https://doi.org/10.7150/ijms.130934
https://pubmed.ncbi.nlm.nih.gov/41938503/
Rubis, A., & Juodzbalys, G. (2020). The Use of Botulinum Toxin A in the Management of Trigeminal Neuralgia: a Systematic Literature Review. Journal of oral & maxillofacial research, 11(2), e2. https://doi.org/10.5037/jomr.2020.11202
https://pmc.ncbi.nlm.nih.gov/articles/PMC7393930/
Forster, A. J., Asmis, T. R., Clark, H. D., Al Saied, G., Code, C. C., Caughey, S. C., Baker, K., Watters, J., Worthington, J., van Walraven, C., & Ottawa Hospital Patient Safety Study (2004). Ottawa Hospital Patient Safety Study: incidence and timing of adverse events in patients admitted to a Canadian teaching hospital. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 170(8), 1235–1240. https://doi.org/10.1503/cmaj.1030683
https://pubmed.ncbi.nlm.nih.gov/15078845/
O'Leary, J. D., Wunsch, H., Leo, A. M., Levin, D., Siddiqui, A., & Crawford, M. W. (2019). Hospital admission on weekends for patients who have surgery and 30-day mortality in Ontario, Canada: A matched cohort study. PLoS medicine, 16(1), e1002731. https://doi.org/10.1371/journal.pmed.1002731